Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · IEX Real-Time Price · USD
5.34
-0.47 (-8.09%)
May 17, 2024, 4:00 PM EDT - Market closed
Sight Sciences Market Cap
Sight Sciences has a market cap or net worth of $266.71 million as of May 17, 2024. Its market cap has decreased by -44.85% in one year.
Market Cap
266.71M
Enterprise Value
173.12M
1-Year Change
-44.85%
Ranking
Category
Stock Price
$5.34
Market Cap Chart
Since the IPO on July 15, 2021, Sight Sciences's market cap has decreased from $1.08B to $266.71M, a decrease of -75.34%. That is a compound annual growth rate of -38.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 265.70M | -8.09% |
May 16, 2024 | 289.10M | 4.71% |
May 15, 2024 | 276.10M | 1.81% |
May 14, 2024 | 271.20M | 0.56% |
May 13, 2024 | 269.70M | 0.94% |
May 10, 2024 | 267.20M | -3.40% |
May 9, 2024 | 276.60M | 0.18% |
May 8, 2024 | 276.10M | -1.78% |
May 7, 2024 | 281.10M | -2.94% |
May 6, 2024 | 289.60M | -1.93% |
May 3, 2024 | 295.30M | 6.22% |
May 2, 2024 | 278.00M | 0.36% |
May 1, 2024 | 277.00M | 0.73% |
Apr 30, 2024 | 275.00M | -4.65% |
Apr 29, 2024 | 288.40M | 10.24% |
Apr 26, 2024 | 261.60M | 2.71% |
Apr 25, 2024 | 254.70M | -8.55% |
Apr 24, 2024 | 278.50M | -0.36% |
Apr 23, 2024 | 279.50M | 5.04% |
Apr 22, 2024 | 266.10M | 4.68% |
Apr 19, 2024 | 254.20M | -2.12% |
Apr 18, 2024 | 259.70M | -2.59% |
Apr 17, 2024 | 266.60M | 2.85% |
Apr 16, 2024 | 259.20M | -5.40% |
Apr 15, 2024 | 274.00M | -4.83% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Black Diamond Therapeutics | 276.20M |
Viemed Healthcare | 275.63M |
MacroGenics | 274.34M |
Acrivon Therapeutics | 273.26M |
AirSculpt Technologies | 270.58M |
Metagenomi | 263.43M |
AxoGen | 263.32M |
Rani Therapeutics Holdings | 263.19M |